Cavu Advisors, LLC, 10% Owner at Lantern Pharma Inc. (LTRN), sold 56,237 shares at $3.03 ($168K) on 2025-05-29, disclosed to the SEC on 2025-05-29.
Open-market sale of $168k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.05 | 1,000 | $3K | 1.8% |
| 2 | $3.05 | 2,290 | $7K | 4.1% |
| 3 | $3.05 | 3,790 | $12K | 6.9% |
| 4 | $3.05 | 6,479 | $20K | 11.7% |
| 5 | $3.05 | 7,478 | $23K | 13.5% |
| 6 | $2.87 | 714 |
| $2K |
| 1.2% |
| 7 | $2.87 | 1,632 | $5K | 2.8% |
| 8 | $2.87 | 2,702 | $8K | 4.6% |
| 9 | $2.87 | 4,620 | $13K | 7.9% |
| 10 | $2.87 | 5,332 | $15K | 9.1% |
| 11 | $3.03 | 961 | $3K | 1.7% |
| 12 | $3.03 | 2,199 | $7K | 4.0% |
| 13 | $3.03 | 3,639 | $11K | 6.5% |
| 14 | $3.03 | 6,221 | $19K | 11.2% |
| 15 | $3.03 | 7,180 | $22K | 12.9% |
| Total | $2.99 avg | 56,237 | $168K | 100% |
| Filing → |
| AZTR | BUY | 2023-06-23 | $3.0M | — | Filing → |
| INAB | BUY | 2022-08-30 | $165K | — | Filing → |